Entries by Lelonie Luft

Reditus ‘on the front lines in the fight against cancer

Reditus Laboratories is excited to bring on our first biomarker as we move to the forefront of malignancy and precision pathology.
The test will determine whether patients with certain cancers are good candidates for a specific cancer treatment and soon will be available at Reditus.

Reditus Labs Stays Focused Despite Demand

Dr. Aaron Rossi of Reditus Laboratories in Pekin joins The Greg and Dan Show for a look at the latest sequencing data from December 2021 to January 2022, the differences between the Delta and Omicron variants, and why PCR tests provide the most accurate results.